Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “P2Y12 Inhibitor”

41 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 41 results

Testing effectiveness (Phase 2)Looking for participantsNCT05926271
What this trial is testing

POPular GUILTY PILOT: Genotype-guided Clopidogrel Monotherapy

Who this might be right for
Acute Coronary SyndromeCYP2C19 Polymorphism
St. Antonius Hospital 200
Testing effectiveness (Phase 2)Study completedNCT00751231
What this trial is testing

Safety and Efficacy Study of PRT060128, a Novel Intravenous and Oral P2Y12 Inhibitor, in Non-Urgent PCI

Who this might be right for
Percutaneous Coronary Intervention
Portola Pharmaceuticals 652
Post-approval studies (Phase 4)Study completedNCT04006288
What this trial is testing

Switching From DAPT to Dual Pathway Inhibition With Low-dose Rivaroxaban in Adjunct to Aspirin in Patients With Coronary Artery Disease

Who this might be right for
Coronary Artery Disease
University of Florida 90
Testing effectiveness (Phase 2)Ended earlyNCT00546260
What this trial is testing

Safety and Efficacy Study of Adjunctive Antiplatelet Therapy Prior to Primary PCI in Patients With STEMI

Who this might be right for
Myocardial Infarction
Alexion Pharmaceuticals, Inc. 70
Not applicableStudy completedNCT05581238
What this trial is testing

Validation of a Red Blood Cell Transfusion Prediction Model in a Low Transfusion Rate Population.

Who this might be right for
Platelet AggregationBlood Transfusion
Medisch Spectrum Twente 6,428
Post-approval studies (Phase 4)Ended earlyNCT03119012
What this trial is testing

P2Y12 Inhibitor Monotherapy Versus Extended DAPT in Patients Treated With Bioresorbable Scaffold

Who this might be right for
Coronary Artery DiseaseStentsAtherosclerosis
Samsung Medical Center 25
Post-approval studies (Phase 4)Study completedNCT01950416
What this trial is testing

Ticagrelor vs High Dose Clopidogrel in Patients With ST Elevation Myocardial Infarction Post Fibrinolysis

Who this might be right for
ST Elevation Myocardial InfarctionFibrinolysisP2Y12 Inhibitor
University of Patras 56
Not applicableStudy completedNCT04492423
What this trial is testing

VerifyNow® PRUTest® Cardiovascular Population Expected Values On-Drug Study

Who this might be right for
Coronary DiseasePlatelet Aggregation
Accriva Diagnostics 100
Post-approval studies (Phase 4)Active Not RecruitingNCT05767723
What this trial is testing

Platelet Sub-study of the Neomindset Trial

Who this might be right for
Acute Coronary Syndrome
Hospital Israelita Albert Einstein 48
Not applicableStudy completedNCT05858918
What this trial is testing

Ticagrelor vs. Clopidogrel in Post PCI Patients

Who this might be right for
Stable Chronic Angina
Shiraz University of Medical Sciences 476
Post-approval studies (Phase 4)Study completedNCT02018055
What this trial is testing

TicAgrelor Versus CLOpidogrel in Stabilized Patients With Acute Myocardial Infarction: TALOS-AMI

Who this might be right for
Acute Myocardial Infarction
The Catholic University of Korea 2,590
Post-approval studies (Phase 4)UnknownNCT03103685
What this trial is testing

Continue vs. Stop P2Y12 Inhibitor on Bleeding in Patient Receiving DAPT Undergoing Dental Procedure.

Who this might be right for
Dental DiseasesAntiplatelet AgentsAntiplatelet Drugs
Chiang Mai University 428
Post-approval studies (Phase 4)Looking for participantsNCT06283888
What this trial is testing

CYP2C19 Genotype-Guided P2Y12 Receptor Inhibitor Selection After Complex Percutaneous Coronary Intervention

Who this might be right for
ACS - Acute Coronary SyndromeCYP2C19 Polymorphism
Zunyi Medical College 1,200
Not applicableLooking for participantsNCT06714526
What this trial is testing

Effect of Genotype-Guided Oral P2Y12 Inhibitor Selection vs Conventional Clopidogrel Therapy in Symptomatic ICAD

Who this might be right for
Intracranial Atherosclerosis
Sunnybrook Health Sciences Centre 100
Not applicableStudy completedNCT04702113
What this trial is testing

Evaluating Pharmacogenomic Variants for Cardiology Therapeutics

Who this might be right for
ThrombosisStent ThrombosisBleeding+2 more
Cipherome, Inc. 300
Large-scale testing (Phase 3)Study completedNCT02617290
What this trial is testing

Assessment of Loading With the P2Y12 Inhibitor Ticagrelor or Clopidogrel to Halt Ischemic Events in Patients Undergoing Elective Coronary Stenting

Who this might be right for
Coronary Artery DiseaseMyocardial IschemiaMyocardial Infarction+2 more
Assistance Publique - Hôpitaux de Paris 1,900
Not applicableLooking for participantsNCT04923191
What this trial is testing

The PIONEER-IV Study is Comparing Clinical Outcomes Between Angiography-derived Physiology Guidance to Usual Care in an All-comers PCI Population With Unrestrictive Use of the HT Supreme Sirolimus-eluting Stent

Who this might be right for
Coronary Artery Disease
National University of Ireland, Galway, Ireland 2,540
Post-approval studies (Phase 4)Looking for participantsNCT05955365
What this trial is testing

Monotherapy With P2Y12 Inhibitors in Patients With Atrial fIbrillation Undergoing Supraflex Stent Implantation

Who this might be right for
Percutaneous Coronary Intervention (PCI)Atrial Fibrillation (AF)Oral Anticoagulation+1 more
Insel Gruppe AG, University Hospital Bern 3,010
Post-approval studies (Phase 4)Looking for participantsNCT05491200
What this trial is testing

Comparison Of Reduced DAPT Followed by P2Y12 Inhibitor Monotherapy With Prasugrel vs stAndard Regimen in STEMI Patients

Who this might be right for
ST Elevated Myocardial InfarctionDual Antiplatelet Therapy
Research Maatschap Cardiologen Rotterdam Zuid 1,656
Post-approval studies (Phase 4)Ended earlyNCT03729401
What this trial is testing

Personalization of Long-Term Antiplatelet Therapy - RAPID EXTEND

Who this might be right for
Coronary Artery DiseaseMyocardial Infarction
Ottawa Heart Institute Research Corporation 39
Next Page